FDA approves new drug for enzyme replacement
The U.S. Food and Drug Administration announced recently the approval of Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods. (Source: Drug Topics - Clinical News)

Video: Obama pledges $130M for Alzheimer's research
President Obama pledged $130 million for Alzheimer's disease research over the next two years, and an additional $26 million to support caregivers. But, will that funding be enough to make a difference? Dr. Jon LaPook reports. (Source: Health News: CBSNews.com)